Nash; Andrew Donald
Patent Applications and Registrations
Patent applications and USPTO patent grants for Nash; Andrew Donald.The latest application filed is for "antibody molecule for human gm-csf receptor alpha".
Company Profile
7.21.25
- Nash; Andrew Donald - Kew AU
- Nash; Andrew Donald - Parkville AU
- Nash; Andrew Donald - Victoria AU
- Nash; Andrew Donald - Melbourne AU
Patent Activity
| Patent | Date |
|---|---|
| Antibody Molecule For Human Gm-csf Receptor Alpha App 20210147559 - Cohen; Emma Suzanne ; et al. | 2021-05-20 |
| Antibodies Against G-csfr And Uses Thereof App 20210009701 - Nash; Andrew Donald ; et al. | 2021-01-14 |
| Antibody Molecule For Human Gm-csf Receptor Alpha App 20190309077 - Cohen; Emma Suzanne ; et al. | 2019-10-10 |
| Antibodies Against G-csfr And Uses Thereof App 20190055313 - Nash; Andrew Donald ; et al. | 2019-02-21 |
| Antibody Molecule For Human Gm-csf Receptor Alpha App 20190040145 - Cohen; Emma Suzanne ; et al. | 2019-02-07 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 10,106,617 - Nash , et al. October 23, 2 | 2018-10-23 |
| High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20170369579 - Nash; Andrew Donald ; et al. | 2017-12-28 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 9,777,062 - Nash , et al. October 3, 2 | 2017-10-03 |
| Antibodies Against G-csfr And Uses Thereof App 20170226214 - Nash; Andrew Donald ; et al. | 2017-08-10 |
| High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20160362497 - Nash; Andrew Donald ; et al. | 2016-12-15 |
| Method of treating pulmonary disease by administering an antibody to G-CSF Grant 9,376,682 - Crump , et al. June 28, 2 | 2016-06-28 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 9,371,388 - Nash , et al. June 21, 2 | 2016-06-21 |
| Antibodies Against G-csfr And Uses Thereof App 20160031998 - Nash; Andrew Donald ; et al. | 2016-02-04 |
| Antibody Molecule For Human GM-CSF Receptor Alpha App 20150376285 - Cohen; Emma Suzanne ; et al. | 2015-12-31 |
| Antibodies against G-CSFR and uses thereof Grant 9,193,793 - Nash , et al. November 24, 2 | 2015-11-24 |
| Antibody molecule for human GM-CSF receptor alpha Grant 9,085,628 - Cohen , et al. July 21, 2 | 2015-07-21 |
| Antibody Molecule For Human Gm-csf Receptor Alpha App 20140079708 - Cohen; Emma Suzanne ; et al. | 2014-03-20 |
| Treatment Of Pulmonary Disease Conditions App 20140056882 - CRUMP; David Eric ; et al. | 2014-02-27 |
| High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20140056915 - Nash; Andrew Donald ; et al. | 2014-02-27 |
| Anti-IL-13R.alpha.1 antibodies and their uses thereof Grant 8,613,925 - Nash , et al. December 24, 2 | 2013-12-24 |
| Method of treating pulmonary disease by administering an antibody to G-CSF receptor Grant 8,574,572 - Crump , et al. November 5, 2 | 2013-11-05 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 8,568,722 - Nash , et al. October 29, 2 | 2013-10-29 |
| Antibody molecule for human GM-CSF receptor alpha Grant 8,506,960 - Cohen , et al. August 13, 2 | 2013-08-13 |
| Antibodies Against G-csfr And Uses Thereof App 20120321630 - NASH; Andrew Donald ; et al. | 2012-12-20 |
| Antibody molecule for human GM-CSF receptor alpha Grant 8,263,075 - Cohen , et al. September 11, 2 | 2012-09-11 |
| Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1) Grant 8,221,755 - Dunlop , et al. July 17, 2 | 2012-07-17 |
| Antibody antagonists of interleukin-13 receptor .alpha.1 Grant 8,207,304 - Nash , et al. June 26, 2 | 2012-06-26 |
| Binding Member For Gm-csf Receptor App 20120141464 - Cohen; Emma Suzanne ; et al. | 2012-06-07 |
| Methods of treating inflammatory airway conditions by inhibition of IL-11 activity Grant 8,182,814 - Baca , et al. May 22, 2 | 2012-05-22 |
| Immunopotentiating Composition App 20110217366 - FUJIOKA; Keiji ; et al. | 2011-09-08 |
| Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof App 20110052597 - Nash; Andrew Donald ; et al. | 2011-03-03 |
| Monoclonal Antibody Against Interleukin-13 Receptor Alpha 1 (il-13ralpha1) App 20110020363 - DUNLOP; Felicity Meredith ; et al. | 2011-01-27 |
| High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1 App 20100285035 - Nash; Andrew Donald ; et al. | 2010-11-11 |
| Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1) Grant 7,785,590 - Dunlop , et al. August 31, 2 | 2010-08-31 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 7,754,213 - Nash , et al. July 13, 2 | 2010-07-13 |
| Treatment Of Pulmonary Disease Conditions App 20090324591 - Crump; David Eric ; et al. | 2009-12-31 |
| Antibody Antagonists of Interleukin-13 Receptor Alpha1 App 20090285799 - Nash; Andrew Donald ; et al. | 2009-11-19 |
| Treatment And Prophylaxis Of Th2 Mediated Disorders App 20090202533 - BACA; Manuel ; et al. | 2009-08-13 |
| Binding Member For Gm-csf Receptor App 20090130093 - Cohen; Emma Suzanne ; et al. | 2009-05-21 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 App 20080166343 - Nash; Andrew Donald ; et al. | 2008-07-10 |
| Monoclonal antibody against Interleukin-13 receptor alpha 1 (IL-13Ralpha1) App 20050058645 - Dunlop, Felicity Meredith ; et al. | 2005-03-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 